TY  - GEN
AU  - Muggia,F M
AU  - Liu,P Y
AU  - Alberts,D S
AU  - Wallace,D L
AU  - O'Toole,R V
AU  - Terada,K Y
AU  - Franklin,E W
AU  - Herrer,G W
AU  - Goldberg,D A
AU  - Hannigan,E V
TI  - Intraperitoneal mitoxantrone or floxuridine: effects on time-to-failure and survival in patients with minimal residual ovarian cancer after second-look laparotomy--a randomized phase II study by theSouthwest Oncology Group
SN  - 0090-8258
PY  - 1996///0712
KW  - Adult
KW  - Aged
KW  - Antimetabolites, Antineoplastic
KW  - administration & dosage
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - therapeutic use
KW  - Female
KW  - Floxuridine
KW  - Humans
KW  - Infusions, Parenteral
KW  - Laparotomy
KW  - Middle Aged
KW  - Mitoxantrone
KW  - Neoplasm, Residual
KW  - Ovarian Neoplasms
KW  - drug therapy
KW  - Reoperation
KW  - Survival Analysis
KW  - Treatment Outcome
N1  - Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, U.S. Gov't, P.H.S
UR  - https://doi.org/10.1006/gyno.1996.0163
ER  -